It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Pfizer (NYSE:PFE) has entered into a collaborative research agreement with Atavistik Bio for the discovery of novel precision ...

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

Susan Sharfstein, a professor at UAlbany's College of Nanotechnology, Science and Engineering, partners with DeepSeq.AI on a ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.

Indian contract drugmaker Anthem Biosciences files for $397 million IPO amid booming Indian market for public offerings.

The start-up – founded by investment group Flagship Pioneering – said that OPL-0401 did not meet either the primary or ...

Building on the success of the anti-Myostatin program, iBio Launches New Program Featuring Myostatin + Activin A Bispecific ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a ...

Anthem Biosciences, a CRDMO specializing in drug discovery, development and manufacturing, has filed draft papers with Sebi ...